These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10842509)

  • 21. Concurrent antibiotic-use review in a small hospital.
    Kerns MP; Meyer GE
    Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacy practice in a small pediatric hospital.
    Oakley RS
    Am J Hosp Pharm; 1984 Apr; 41(4):694-7. PubMed ID: 6720711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing the hospital pharmacy. Interview by Nancy M. Agresta.
    Lantos RL
    Hosp Formul; 1979 Sep; 14(9):839-43. PubMed ID: 10243910
    [No Abstract]   [Full Text] [Related]  

  • 24. [Create or strengthen the drug committee at a hospital].
    Bruneton C
    Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 26. Computerized drug inventory controls on a budget.
    Elliott RK
    Hosp Pharm; 1975 May; 10(5):184, 187-9. PubMed ID: 10316964
    [No Abstract]   [Full Text] [Related]  

  • 27. Twenty-four hour pharmacy service in hospitals with less than 300 beds--part 2.
    Davis NM
    Hosp Pharm; 1983 Aug; 18(8):421-8. PubMed ID: 10261792
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use.
    Vargas-Rivas JE; Sabater-Hernández D; Calleja-Hernández MA; Faus MJ; Martínez-Martínez F
    Int J Clin Pharm; 2011 Oct; 33(5):719-21; author reply 722-3. PubMed ID: 21847687
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 31. A multidisciplinary approach to pharmaceutical inventory control.
    Rinehart JR
    Top Hosp Pharm Manage; 1989 Aug; 9(2):31-7. PubMed ID: 10314357
    [No Abstract]   [Full Text] [Related]  

  • 32. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electronic data interchange for pharmacy inventory control.
    Neal TA; Whiteman J; Swenson JP
    Am J Hosp Pharm; 1990 Nov; 47(11):2483-7. PubMed ID: 2278259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacy service to distant small hospitals.
    Moleschi M; Cseke W; Roy L
    Can J Hosp Pharm; 1989 Aug; 42(4):157-9. PubMed ID: 10294301
    [No Abstract]   [Full Text] [Related]  

  • 36. Formulary status of intravenous immunoglobulins in selected hospitals.
    Hatton RC; Doering PL; Fakhoury M; Williams RB
    Am J Hosp Pharm; 1988 Nov; 45(11):2377-9. PubMed ID: 3228096
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.
    Mashaba TP; Matlala M; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):159-168. PubMed ID: 30407089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Space requirements for pharmaceutical functions in selected nonuniversity hospitals.
    Fricker MP; Davis NM
    Hosp Pharm; 1983 Dec; 18(12):645-7, 650-2, 655-9 passim. PubMed ID: 10264359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inter-role relationships in hospital-based pharmacy and therapeutics committee decision making.
    Bagozzi RP; Ascione FJ; Mannebach MA
    J Health Psychol; 2005 Jan; 10(1):45-64. PubMed ID: 15576500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the director of pharmacy: the first six months.
    Nold EG; Sander WT
    Am J Health Syst Pharm; 2004 Nov; 61(21):2297-310. PubMed ID: 15552639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.